Addition of Chidamide to a Sandwich Protocol, Pegaspargase, Gemcitabine and Oxaliplatin Chemotherapy Combined with Radiotherapy, As First-Line Treatment in Early Stage NK/T-Cell Lymphoma: Real World Outcomes in a Retrospective Study

被引：0
|
作者：
Xia, Fan [1 ]
Ping, Nana [2 ]
Bao, Qi [1 ]
Zou, Rui [2 ]
Zhu, Qian [2 ]
Zhang, Xiao [2 ]
Wu, Depei [3 ]
Jin, Zhengming [2 ]
Qu, Changju [2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Pharm, Suzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Inst Blood & Marrow Transplantat, Dept Hematol,Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
Extranodal NK/T-cell lymphoma; chidamide; pegaspargase; gemcitabine; radiation therapy;
D O I：
10.1182/blood-2023-177828
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] First-line LVDP (l-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type
    Wanchun Wu
    Xi Chen
    Na Li
    Qian Luo
    Liqun Zou
    Annals of Hematology, 2022, 101 : 1557 - 1565
  • [32] First-line LVDP (L-asparaginase, etoposide, dexamethasone, and cisplatin) regimen combined with radiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma, nasal type
    Wu, Wanchun
    Chen, Xi
    Li, Na
    Luo, Qian
    Zou, Liqun
    ANNALS OF HEMATOLOGY, 2022, 101 (07) : 1557 - 1565
  • [33] Phase II/III randomized trial of CID-ATT with radiotherapy compared with CHOP with radiotherapy as first-line treatment for previously untreated early staging extranodal NK/T-cell lymphoma, nasal type (ENKL)
    Lin, Tongyu
    Huang, He
    Liang, Chao Yong
    Guo, Chengcheng
    Tian, Ying
    Liu, Tingzhi
    Li, Xue Ying
    Zhang, Mengping
    Hong, Huang Ming
    Shrestha, Prem Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Treatment Outcomes and Prognostic Factors of Chemotherapy Combined with Radiotherapy for Patients with Stage I-II Nasal-Type Natural Killer/T-Cell Lymphoma
    Wang, S.
    Ou, D.
    Cao, L.
    Xu, C.
    Cao, W.
    Chen, J.
    Cai, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E491 - E491
  • [35] First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study
    Meeuwes, Frederik O.
    Brink, Mirian
    Van Der Poel, Marjolein W. M.
    Kersten, Marie Jose
    Wondergem, Marielle
    Mutsaers, Pim G. N. J.
    Boehmer, Lara H.
    Woei-a-Jin, F. J. Sherida H.
    Visser, Otto J.
    Oostvogels, Rimke
    Jansen, Patty M.
    Neelis, Karen J.
    Crijns, Anne P. G.
    Daniels, Laurien A.
    Vermaat, Joost S. P.
    Huls, Gerwin A.
    Nijland, Marcel
    BLOOD, 2021, 138
  • [36] A retrospective real-world study of nimotuzumab combined with chemotherapy for first-line treatment of advanced pancreatic cancer: A single center propensity score matched analysis
    Wu, Y.
    Dong, X.
    Li, E.
    Fan, Y.
    Dong, D.
    Shi, Y.
    Wang, M.
    Yang, N.
    Ou, F.
    Wang, J.
    Yang, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S920 - S920
  • [37] Efficacy analysis and prognostic factors of first-line chemotherapy combined with immunotherapy in extensive-stage small cell lung cancer: a real-world study
    Jian-Xi Zhou
    Yun-Chuan Sun
    Li Xiao
    Hong-Ling Lu
    Xiao-Ming Yin
    Kui Fan
    Ying-Nan Zhou
    Scientific Reports, 15 (1)
  • [38] First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma
    Wang, Liang
    Wang, Zhi-hui
    Chen, Xiao-qin
    Li, Ya-jun
    Wang, Ke-feng
    Xia, Yun-fei
    Xia, Zhong-jun
    CANCER, 2013, 119 (02) : 348 - 355
  • [39] Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study
    Wei, Liqiang
    Wang, Jingwen
    Ye, Jin
    Yang, Lei
    Cong, Jia
    Li, Xin
    Wu, Yiping
    Cui, Xueying
    Ding, Jing
    Yao, Na
    Yang, Jing
    LEUKEMIA & LYMPHOMA, 2020, 61 (02) : 337 - 343
  • [40] PD-L1 Inhibitors Combined with Thoracic Radiotherapy in First-Line Treatment of Extensive Stage Small Cell Lung Cancer: A Propensity Score-Matched, Real -World Study
    Peng, J.
    Zhang, L.
    Wang, L.
    Feng, H.
    Yao, D.
    Meng, R.
    Liu, X.
    Li, X.
    Liu, N.
    Tan, B.
    Huang, Z.
    Li, S.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S127 - S128
12345